A MicroRNA Expression Signature In Taxane-anthracycline-based Neoadjuvant Chemotherapy Response

Zheng, Yi; Li, Shuai; Boohaker, Rebecca J; Liu, Xinli; Zhu, Yufen; Zhai, Lili; Li, Huilan; Gu, Feng; Fan, Yu; Lang, Ronggang; Liu, Fangfang; Qian, Xiaolong; Xu, Bo; Fu, Li

doi:10.7150/jca.11616



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2015; 6(7):671-677. doi:10.7150/jca.11616 This issue Cite

Research Paper

A MicroRNA Expression Signature In Taxane-anthracycline-based Neoadjuvant Chemotherapy Response

Yi Zheng^1,*, Shuai Li^1,*, Rebecca J Boohaker³, Xinli Liu¹, Yufen Zhu¹, Lili Zhai¹, Huilan Li¹, Feng Gu¹, Yu Fan¹, Ronggang Lang¹, Fangfang Liu¹, Xiaolong Qian¹, Bo Xu³, Li Fu^1,2,✉

1. Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education; Key Laboratory of Cancer Prevention and Therapy, Tianjin; State Key Laboratory of Breast Cancer Research, Hexi District, Tianjin, 300060, China
2. 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics
3. Department of Oncology, Southern Research Institute, Birmingham, AL 35205, USA
^*These authors contributed equally to this work.

Citation:

Zheng Y, Li S, Boohaker RJ, Liu X, Zhu Y, Zhai L, Li H, Gu F, Fan Y, Lang R, Liu F, Qian X, Xu B, Fu L. A MicroRNA Expression Signature In Taxane-anthracycline-based Neoadjuvant Chemotherapy Response. J Cancer 2015; 6(7):671-677. doi:10.7150/jca.11616. https://www.jcancer.org/v06p0671.htm

Other styles

Abstract

There is an unmet clinical need to identify biomarkers for breast cancer neoadjuvant chemotherapy. Here, using miRNA TaqMan Low-Density Arrays (TLDA), we analyzed the miRNA expression profile in pre-treatment needle aspiration tumor samples from patients who received taxane-anthracycline-based neoadjuvant chemotherapy. Although, in an unsupervised hierarchical cluster analysis, the total miRNA expression profile could not generate a tree with clear distinction between pathologic complete response (pCR) and non-pCR classes, we found that elevated expression of miR-125b and miR-141 was associated with non-pCR. In vitro experiments indicated that inhibition of miR-125b and miR-141 expression reduced cellular survival in response to taxane-anthracycline treatment. Furthermore, co-transfection with miR-125b and miR-141 mimics increased resistance of MCF7 and BT549 cells to taxane-anthracycline induced cytotoxicity. Pathway analyses indicated that many of the target proteins of miR-125b are involved in apoptotic pathways and cell cycle control. Together, we provide evidence that elevated miR-125b and 141 expression predicts a poor clinical responsiveness of taxane-anthracycline-based neoadjuvant chemotherapy.

Keywords: breast cancer, microRNA, neoadjuvant chemotherapy, pathologic complete response, predictive biomarkers.

Citation styles

APA

Zheng, Y., Li, S., Boohaker, R.J., Liu, X., Zhu, Y., Zhai, L., Li, H., Gu, F., Fan, Y., Lang, R., Liu, F., Qian, X., Xu, B., Fu, L. (2015). A MicroRNA Expression Signature In Taxane-anthracycline-based Neoadjuvant Chemotherapy Response. Journal of Cancer, 6(7), 671-677. https://doi.org/10.7150/jca.11616.

ACS

Zheng, Y.; Li, S.; Boohaker, R.J.; Liu, X.; Zhu, Y.; Zhai, L.; Li, H.; Gu, F.; Fan, Y.; Lang, R.; Liu, F.; Qian, X.; Xu, B.; Fu, L. A MicroRNA Expression Signature In Taxane-anthracycline-based Neoadjuvant Chemotherapy Response. J. Cancer 2015, 6 (7), 671-677. DOI: 10.7150/jca.11616.

NLM

CSE

Zheng Y, Li S, Boohaker RJ, Liu X, Zhu Y, Zhai L, Li H, Gu F, Fan Y, Lang R, Liu F, Qian X, Xu B, Fu L. 2015. A MicroRNA Expression Signature In Taxane-anthracycline-based Neoadjuvant Chemotherapy Response. J Cancer. 6(7):671-677.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.